Equities

Evaxion Biotech A/S

EVAX:NAQ

Evaxion Biotech A/S

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.84
  • Today's Change-0.01 / -0.35%
  • Shares traded35.89k
  • 1 Year change-67.07%
  • Beta-0.2442
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

  • Revenue in USD (TTM)278.00k
  • Net income in USD-15.21m
  • Incorporated2008
  • Employees49.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Protext Mobility Inc750.00-2.21m14.95m4.00------19,926.77-0.4692-0.46920.00001-0.01020.0405-------9,400.97-1,587.94----86.67-530.19-232,392.00-17,498.830.0002-1.36-----93.98-63.0927.35------
Apollomics Inc0.00-57.11m15.62m45.00--0.7505-----0.568-0.5680.000.18920.00----0.00-107.81---144.29--------------0.185------28.33------
Evaxion Biotech A/S - ADR278.00k-15.21m15.84m49.00--12.26--56.96-36.98-36.980.10480.23160.0174--0.34935,673.47-95.08-100.11-126.11-131.65-----5,469.42-131,560.30----0.8933------4.51--65.53--
NRX Pharmaceuticals Inc0.00-24.83m15.91m2.00---------1.62-1.620.00-1.700.00-------197.97-120.57---168.40-----------189.12--------24.14------
Cognition Therapeutics Inc0.00-31.08m16.05m25.00--0.6973-----0.9317-0.93170.000.57360.00----0.00-79.36---104.49-------------263.290.00-------20.52------
Athira Pharma Inc0.00-113.45m16.25m65.00--0.195-----2.97-2.970.002.170.00----0.00-71.06-30.73-83.81-32.46------------0.00-------23.04------
Mira Pharmaceuticals Inc0.00-12.78m16.26m3.00--7.33-----0.8562-0.85620.000.15010.00----0.00-373.77---737.47-------------3.170.00-------69.77------
OpGen Inc1.96m-22.39m16.29m100.00------8.29-20.01-20.011.66-8.650.1553--6.09---176.99-87.95-15,455.17-127.653.1515.42-1,139.66-794.78---20.25----31.113.0212.38--40.20--
Matinas BioPharma Holdings Inc0.00-22.91m16.50m32.00--0.8639-----5.10-5.100.003.810.00----0.00-78.48-44.62-85.80-48.25-------2,344.60----0.001---65.6255.71-9.26---16.46--
AIM ImmunoTech Inc201.00k-28.05m16.59m26.00--2.45--82.54-0.5703-0.57030.0040.10680.0082--12.187,730.77-113.70-45.64-149.16-48.3571.14-231.75-13,952.74-11,695.01----0.3018--43.26-11.26-48.94--35.73--
Microbot Medical Inc0.00-10.44m16.83m22.00--2.69-----0.81-0.810.000.37930.00----0.00-113.94-53.28-133.34-62.65------------0.00------18.44---31.76--
Geovax Labs Inc300.68k-26.92m16.88m17.00------56.14-13.05-13.050.1389-0.55260.0237----17,687.06-212.40-108.34-362.39-147.24-----8,951.51-1,842.93---------100.00---85.20------
Biomx Inc0.00-26.25m17.00m58.00---------0.4575-0.45750.000.39290.00----0.00-47.79---57.76--------------0.00------7.59------
Palatin Technologies, Inc.4.49m-29.74m17.02m30.00------3.79-1.97-1.970.2981-0.00620.31310.37133.08149,669.70-207.35-55.28-1,527.99-69.0897.83---662.26-1,359.141.01-------7.49-40.52-23.71--3.31--
Data as of Oct 08 2024. Currency figures normalised to Evaxion Biotech A/S's reporting currency: US Dollar USD

Institutional shareholders

7.31%Per cent of shares held by top holders
HolderShares% Held
Armistice Capital LLCas of 31 Mar 2024367.00k7.04%
Citadel Securities LLCas of 31 Mar 20248.14k0.16%
Beacon Capital Management LLC (Tennessee)as of 30 Jun 20244.86k0.09%
JPMorgan Securities LLC (Investment Management)as of 31 Mar 2024705.000.01%
RhumbLine Advisers LPas of 30 Jun 2024290.000.01%
Tower Research Capital LLCas of 31 Mar 202430.000.00%
South State Advisory, Inc.as of 30 Jun 20244.000.00%
Group One Trading LPas of 31 Mar 20240.000.00%
UBS Securities LLCas of 31 Mar 20240.000.00%
LM Advisors LLCas of 31 Mar 20240.000.00%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.